Medsir

This study is testing a drug called repotrectinib for people with a specific type of lung cancer (ROS1-positive NSCLC) that has spread to the brain. The main goal is to see if the drug is safe and can shrink or control the brain tumors. It will enroll about 20 participants who wi…

This study is testing whether adding the drug everolimus to a newer hormone therapy (elacestrant) works better for controlling advanced breast cancer than the hormone therapy alone. It is for people whose cancer has a specific mutation (ESR1) and has continued to grow despite sta…

This study is for people with a specific, harder-to-treat type of advanced breast cancer that is hormone-sensitive but has a non-luminal genetic pattern. It will compare a newer drug called trastuzumab deruxtecan against the current standard treatment (a CDK4/6 inhibitor plus hor…

This study is for people with a common type of early-stage breast cancer who are at higher risk of the cancer coming back. The main goal is to see if a special blood test can find tiny traces of cancer (called ctDNA) before a person feels sick or a scan shows anything. If the blo…

This study is testing whether giving the drug niraparib again after surgery can help control ovarian cancer that has returned in a limited way. It will include 30 women whose cancer spread to 1-5 spots after previous treatment with similar drugs. The main goal is to see how long …